Targeting vasoactive peptides for managing calcific aortic valve disease (Q38943935)

7 September 2017

1 reference

title

Targeting vasoactive peptides for managing calcific aortic valve disease (English)

1 reference

7 September 2017

0 references

Tuomas Peltonen

1

1 reference

7 September 2017

Pauli Ohukainen

series ordinal

2

1 reference

7 September 2017

Heikki Ruskoaho

series ordinal

3

1 reference

7 September 2017

Jaana Rysä

series ordinal

4

1 reference

7 September 2017

language of work or name

English

0 references

publication date

1 September 2016

1 reference

7 September 2017

1 reference

7 September 2017

49

1 reference

7 September 2017

63-74

1 reference

7 September 2017

1

1 reference

Aortic-valve stenosis--from patients at risk to severe valve obstruction

7 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Valvular aortic stenosis in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Natural history of very severe aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Calcific aortic stenosis: a disease of the valve and the myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Interactions between endothelin-1 and the renin-angiotensin-aldosterone system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

AT2 receptor agonists: hypertension and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Induction of local angiotensin II-producing systems in stenotic aortic valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Angiotensin II promotes aortic valve thickening independent of elevated blood pressure in apolipoprotein-E deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Is blockade of the Renin-Angiotensin system able to reverse the structural and functional remodeling of the left ventricle in severe aortic stenosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Effects of angiotensin converting enzyme inhibitors in hypertensive patients with aortic valve stenosis: a drug withdrawal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Short-term hemodynamic effect of angiotensin-converting enzyme inhibition in patients with severe aortic stenosis: a placebo-controlled, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

A prospective, double-blind, randomized controlled trial of the angiotensin-converting enzyme inhibitor Ramipril In Aortic Stenosis (RIAS trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Physiology of local renin-angiotensin systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Aortic valvular heart disease: Is there a place for angiotensin-converting-enzyme inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Angiotensin-converting enzyme inhibitors and change in aortic valve calcium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Current management of calcific aortic stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Ramipril retards development of aortic valve stenosis in a rabbit model: mechanistic considerations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Genetically altered animal models for Mas and angiotensin-(1-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

The expression of Mas-receptor of the renin-angiotensin system in the human eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

(Pro)renin receptor promotes choroidal neovascularization by activating its signal transduction and tissue renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Prorenin induces ERK activation in endothelial cells to enhance neovascularization independently of the renin-angiotensin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

New physiological concepts of the renin-angiotensin system from the investigation of precursors and products of angiotensin I metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Antagonist, partial agonist and antiproliferative actions of B-9870 (CU201) as a function of the expression and density of the bradykinin B1 and B2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Bradykinin regulates osteoblast differentiation by Akt/ERK/NFκB signaling axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Endothelin, hypercholesterolemia and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

The importance of endothelin-1 for vascular dysfunction in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Endothelin-1 is a potent regulator in vivo in vascular calcification and in vitro in calcification of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Vitamin D receptor deficiency and low vitamin D diet stimulate aortic calcification and osteogenic key factor expression in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Apelin and its receptor APJ in cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Expression of the murine msr/apj receptor and its ligand apelin is upregulated during formation of the retinal vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

The Apelin-APJ System in the Evolution of Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Apelin attenuates the osteoblastic differentiation of aortic valve interstitial cells via the ERK and PI3-K/Akt pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Apelin prevents cardiac fibroblast activation and collagen production through inhibition of sphingosine kinase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

MicroRNA-125b and chemokine CCL4 expression are associated with calcific aortic valve disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Corin, a transmembrane cardiac serine protease, acts as a pro-atrial natriuretic peptide-converting enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Furin-mediated Processing of Pro-C-type Natriuretic Peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Dwarfism and early death in mice lacking C-type natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Local expression of C-type natriuretic peptide suppresses inflammation, eliminates shear stress-induced thrombosis, and prevents neointima formation through enhanced nitric oxide production in rabbit injured carotid arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Endothelial C-type natriuretic peptide maintains vascular homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Angiotensin-neprilysin inhibition versus enalapril in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Natriuretic peptides in common valvular heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Prognostic value of B-type natriuretic peptide in elderly patients with aortic valve stenosis: the COFRASA-GENERAC study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

B-type natriuretic peptide clinical activation in aortic stenosis: impact on long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Vitamin D and Cardiovascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Big endothelin-1 is not a predictor in aortic stenosis, but is related to arterial blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F07853890.2016.1231933

10.1080/07853890.2016.1231933

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference